Over the past 12 months, 8 insiders at AGIOS PHARMACEUTICALS, INC. filed 44 open-market SEC Form 4 transactions on AGIO: 0 purchases worth $0 and 44 sales worth $4.7M. Insiders have been net sellers over this period. The most recent filing was on Jul 1, 26.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 1, 26 | Sarah GheuensChief Medical Officer | SELL | 4.0K | $37.56 | $151K |
| Apr 2, 26 | James William BurnsChief Legal Officer | SELL | 3.3K | $34.71 | $114K |
| Apr 2, 26 | Sarah GheuensChief Medical Officer | SELL | 2.9K | $34.71 | $102K |
| Apr 2, 26 | Brian GoffChief Executive Officer | SELL | 12.5K | $34.71 | $433K |
| Apr 2, 26 | Cecilia JonesChief Financial Officer | SELL | 3.1K | $34.71 | $109K |
| Apr 2, 26 | Tsveta MilanovaChief Commercial Officer | SELL | 3.3K | $34.71 | $113K |
| Apr 2, 26 | Krishnan ViswanadhanChief Corp Dev & Strategy | SELL | 3.0K | $34.71 | $103K |
| Mar 5, 26 | Krishnan ViswanadhanChief Corp Dev & Strategy | SELL | 3.0K | $27.80 | $82K |
| Mar 3, 26 | Theodore James Washburn Jr.Principal Accounting Officer | SELL | 5.3K | $28.88 | $152K |
| Mar 2, 26 | James William BurnsChief Legal Officer | SELL | 1.7K | $28.96 | $49K |
| Mar 2, 26 | Sarah GheuensChief Medical Officer | SELL | 1.7K | $28.96 | $49K |
| Mar 2, 26 | Brian GoffChief Executive Officer | SELL | 8.3K | $28.96 | $239K |
| Mar 2, 26 | Cecilia JonesChief Financial Officer | SELL | 1.7K | $28.96 | $49K |
| Mar 2, 26 | Tsveta MilanovaChief Commercial Officer | SELL | 1.7K | $28.96 | $49K |
| Mar 2, 26 | Theodore James Washburn Jr.Principal Accounting Officer | SELL | 798 | $28.96 | $23K |
| Jan 5, 26 | Tsveta MilanovaChief Commercial Officer | SELL | 2.9K | $27.02 | $78K |
| Dec 30, 25 | James William BurnsChief Legal Officer | SELL | 2.9K | $27.09 | $79K |
| Dec 30, 25 | Sarah GheuensChief Medical Officer | SELL | 2.9K | $27.09 | $79K |
| Dec 30, 25 | Brian GoffChief Executive Officer | SELL | 12.5K | $27.09 | $338K |
| Dec 30, 25 | Cecilia JonesChief Financial Officer | SELL | 2.9K | $27.09 | $79K |
| Dec 30, 25 | Tsveta MilanovaChief Commercial Officer | SELL | 2.9K | $27.09 | $79K |
| Nov 12, 25 | David ScaddenDirector | SELL | 200 | $43.84 | $9K |
| Nov 11, 25 | Sarah GheuensChief Medical Officer | SELL | 2.5K | $43.78 | $107K |
| Oct 30, 25 | Sarah GheuensChief Medical Officer | SELL | 200 | $43.81 | $9K |
| Oct 27, 25 | Sarah GheuensChief Medical Officer | SELL | 3.3K | $43.92 | $145K |
| Oct 8, 25 | David ScaddenDirector | SELL | 200 | $41.00 | $8K |
| Sep 30, 25 | David ScaddenDirector | SELL | 200 | $40.00 | $8K |
| Sep 26, 25 | Cecilia JonesChief Financial Officer | SELL | 3.7K | $36.77 | $134K |
| Sep 5, 25 | Theodore James Washburn Jr.Principal Accounting Officer | SELL | 8.5K | $36.87 | $315K |
| Aug 27, 25 | David ScaddenDirector | SELL | 200 | $40.00 | $8K |
| Aug 8, 25 | Brian GoffChief Executive Officer | SELL | 11.1K | $36.67 | $406K |
| Jul 10, 25 | David ScaddenDirector | SELL | 1.4K | $40.00 | $56K |
| Jul 9, 25 | Sarah GheuensChief Medical Officer | SELL | 11.1K | $38.76 | $420K |
| Jul 1, 25 | Sarah GheuensChief Medical Officer | SELL | 4.1K | $34.17 | $140K |
| Jun 24, 25 | James William BurnsChief Legal Officer | SELL | 2.8K | $33.54 | $94K |
| Jun 24, 25 | Sarah GheuensChief Medical Officer | SELL | 2.9K | $33.54 | $98K |
| Jun 24, 25 | Brian GoffChief Executive Officer | SELL | 12.5K | $33.54 | $418K |
| Jun 24, 25 | Cecilia JonesChief Financial Officer | SELL | 1.8K | $33.54 | $60K |
| Jun 24, 25 | Tsveta MilanovaChief Commercial Officer | SELL | 2.8K | $33.54 | $93K |
| Apr 10, 25 | Jacqualyn A FouseDirector | SELL | 7.5K | $25.90 | $194K |
| Mar 3, 25 | James William BurnsChief Legal Officer | SELL | 1.7K | $35.54 | $60K |
| Mar 3, 25 | Sarah GheuensChief Medical Officer | SELL | 1.7K | $35.54 | $60K |
| Mar 3, 25 | Brian GoffChief Executive Officer | SELL | 8.8K | $35.54 | $313K |
| Mar 3, 25 | Cecilia JonesChief Financial Officer | SELL | 1.7K | $35.54 | $60K |
| Mar 3, 25 | Tsveta MilanovaChief Commercial Officer | SELL | 1.7K | $35.54 | $60K |
| Mar 3, 25 | Theodore James Washburn Jr.Principal Accounting Officer | SELL | 727 | $35.54 | $26K |
| Feb 5, 25 | Theodore James Washburn Jr.Principal Accounting Officer | SELL | 2.3K | $34.39 | $78K |
| Jan 6, 25 | Tsveta MilanovaChief Commercial Officer | SELL | 2.8K | $32.18 | $90K |
| Dec 11, 24 | David ScaddenDirector | SELL | 200 | $46.28 | $9K |
| Nov 8, 24 | Theodore James Washburn Jr.Principal Accounting Officer | SELL | 772 | $56.09 | $43K |
Over the past 12 months, insiders at AGIOS PHARMACEUTICALS, INC. filed 0 open-market purchases worth $0 and 44 sales worth $4.7M on AGIO, which makes them net sellers over the period. The most recent Form 4 was filed on Jul 1, 26.
8 different insiders at AGIOS PHARMACEUTICALS, INC. filed open-market SEC Form 4 transactions on AGIO over the last 12 months.
InsiderTape plots every AGIO insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every AGIOS PHARMACEUTICALS, INC. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →